Dry Eye Syndrome Treatment Market By Product Type (Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs, Secretagogues), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And Region for 2024-2031

Dry Eye Syndrome Treatment Market Valuation – 2024-2031

The increasing prevalence of dry eye syndrome, particularly among the aging population and increased screen time users, is driving the Dry Eye Syndrome Treatment Market upwards. According to the analyst from Verified Market Research, the Dry Eye Syndrome Treatment Market is estimated to reach a valuation of USD 22.71 Billion in 2031, by subjugating around USD 8.81 Billion valued in 2023.

The rapid expansion of the Dry Eye Syndrome Treatment Market is primarily driven by the rising global demand for effective therapies, as well as technological advancements in treatment options. It enables the market to grow at a CAGR of 13.86% from 2024 to 2031.

>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=61962

To Get Detailed Analysis: Download Report PDF

Dry Eye Syndrome Treatment Market: Definition/ Overview

Dry eye syndrome is a condition characterized by insufficient tear production or rapid tear evaporation, leading to discomfort and potential vision problems. Treatment options for dry eye syndrome include artificial tears, anti-inflammatory medications, and procedures to conserve tears or stimulate tear production.

Furthermore, dry eye syndrome treatments have a wide range of applications, including providing immediate relief from symptoms, managing underlying causes, and preventing further complications. Improved treatments, such as preservative-free formulations and novel drug delivery systems, are enhancing patient outcomes and driving market growth.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=61962

What are the Key Drivers Propelling the Growth of the Dry Eye Syndrome Treatment Market?

Dry eye condition is becoming increasingly common, which is a major market driver. According to the National Eye Institute (NEI), more than 16 million adults in the United States have been diagnosed with DES, with millions more potentially undiagnosed. The growing patient population demands more effective treatment choices.

The aging population is greatly increasing the need for dry eye remedies. According to the World Health Organization (WHO, by 2030, one in every six persons worldwide would be 60 or older. Because dry eye conditions are more common among older persons, the aging population is likely to drive market expansion.

Furthermore, the increase in screen time and digital eye strain is driving demand for dry eye remedies. According to a Vision Council study published in 2020, 59% of American people express symptoms of digital eye strain because of prolonged screen use, which is directly linked to dry eye syndrome. As screen time increases, so does the demand for effective therapies.

What are the Key Challenges Impacting the Adoption of Dry Eye Syndrome Treatment in the Market?

The high expense of innovative treatments for dry eye syndrome is a major barrier to their acceptance. Long-term treatment requires expensive prescription medications, specialist eye drops, and medical devices such as punctual plugs or thermal pulsation systems. Patients in areas with limited healthcare coverage or high out-of-pocket charges face considerable barriers due to these prices. Patients delay therapy or use over-the-counter medicines, which are not beneficial for managing the illness.

Many individuals experiencing symptoms do not seek medical attention, mistaking their condition for temporary discomfort or attributing it to environmental factors. Furthermore, healthcare providers do not always prioritize dry eye syndrome as a significant health issue, especially in the early stages. This lack of awareness and diagnosis hinders the adoption of effective treatments, as patients do not realize the chronic nature of the condition or the availability of specialized therapies that could significantly improve their quality of life.

Furthermore, the variability in treatment effectiveness also poses a challenge in the adoption of dry eye syndrome treatments. Since dry eye syndrome has multiple causes, including environmental factors, hormonal changes, and underlying medical conditions, treatment outcomes vary greatly from one patient to another. Some patients do not respond well to certain therapies or experience side effects that discourage continued use. This unpredictability in treatment response led to patient frustration, reduced compliance with prescribed therapies, and lower overall adoption of advanced treatments designed to manage the condition long-term.

Category-Wise Acumens

What are the Drivers that Contribute to the Demand for Artificial Tears?

According to VMR analysis, the artificial tears segment is estimated to dominate the market in the product type segment during the forecast period. Artificial tears provide immediate relief by lubricating the eyes and are widely available over the counter, making them highly accessible to patients. This widespread availability and ease of use contribute significantly to their market dominance.

Also, technological advancements have led to the development of preservative-free and long-lasting formulations of artificial tears. These innovations have enhanced the efficacy and safety profile of artificial tears, making them more appealing to both patients and healthcare providers. The improved formulations address concerns about preservative-related irritation and offer longer-lasting relief, further driving their popularity in the market.

Furthermore, artificial tears are often recommended as a first-line treatment for dry eye syndrome by eye care professionals. They are suitable for mild to moderate cases of dry eye and be used in conjunction with other treatments for more severe cases. This application’s versatility contributes to their widespread use and market dominance.

What are the Potential Factors for the Growth of Retail Pharmacies in the Market?

The retail pharmacies segment is estimated to dominate the Dry Eye Syndrome Treatment Market during the forecast period. Retail pharmacies offer widespread accessibility and convenience for patients seeking over-the-counter dry eye treatments like artificial tears and lubricating eye drops. They are often the first point of contact for individuals looking for immediate relief from dry eye symptoms, contributing to their market dominance.

The growing number of chain pharmacies and drugstores has significantly expanded the reach of retail pharmacies. These establishments often offer a wide range of dry eye products, from basic artificial tears to more specialized treatments. The convenience of accessing these products alongside other healthcare needs makes retail pharmacies a preferred channel for many consumers.

Furthermore, many retail pharmacies now offer personalized in-store consultations with pharmacists. These consultations provide valuable guidance to customers in selecting appropriate dry eye treatments, enhancing the overall customer experience, and building trust. This personalized approach, combined with the immediate availability of products, strengthens the position of retail pharmacies in the Dry Eye Syndrome Treatment Market.

Gain Access to Dry Eye Syndrome Treatment Market Report Methodology

https://www.verifiedmarketresearch.com/select-licence/?rid=61962

Country/Region-wise Acumens

What are the Key Factors that Contribute to North America’s Edge in the Market?

According to VMR Analyst, North America is estimated to dominate the Dry Eye Syndrome Treatment Market during the forecast period. North America, particularly the U.S., has a high prevalence of dry eye syndrome, driving the demand for treatment options. According to the American Academy of Ophthalmology, approximately 16 million people in the U.S. have been diagnosed with dry eye disease. This large patient population supports the region’s dominance in the market for dry eye treatments.

North America benefits from strong research and development activities in the healthcare sector. This leads to innovative product launches and advanced treatment options for dry eye syndrome. The region’s robust healthcare infrastructure and high awareness of eye health among the population further cement its market dominance.

Furthermore, the increasing use of digital devices and screen time, particularly in the U.S., has contributed to a rising number of dry eye cases. A report from the Vision Council revealed that nearly 80% of American adults use digital devices for more than two hours per day, which significantly increases the risk of developing dry eye. This growing trend is fueling the demand for effective treatments in North America.

How Do Demographic Shifts Shape the Market Landscape in the Asia Pacific?

The Asia Pacific region is estimated to exhibit the highest growth rate within the Dry Eye Syndrome Treatment Market during the forecast period. The rapid urbanization and increasing pollution levels in Asia-Pacific are contributing to the rising prevalence of dry eye syndrome. A study published by the World Health Organization (WHO) highlighted that many major cities in Asia, such as New Delhi and Beijing, experience high levels of air pollution, which exacerbates eye health issues, including dry eye.

The aging population across many countries in the Asia-Pacific region is another significant driver for the Dry Eye Syndrome Treatment Market. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of people aged 60 or older in Asia-Pacific is expected to increase from 630 million in 2020 to 1.3 billion by 2050. As dry eye syndrome is more prevalent among older adults, this demographic shift is contributing to the growing demand for treatment solutions.

Furthermore, the rapid adoption of digital devices, particularly in countries like China, Japan, and India, is fueling the rise in dry eye syndrome cases. According to a report by the Indian Council of Medical Research (ICMR), more than 50% of Indian adults experience digital eye strain due to excessive screen time, leading to a higher prevalence of dry eye symptoms. This growing trend of digital device usage is significantly boosting the demand for dry eye treatments in the Asia-Pacific region.

Competitive Landscape

The Dry Eye Syndrome Treatment Market’s competitive landscape is characterized by a diverse range of companies, including pharmaceutical giants, specialty eye care companies, and innovative startups, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the Dry Eye Syndrome Treatment Market include:

Novartis AG, Allergan plc, Bausch Health Companies Inc., Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Akorn, Inc., Thea Pharmaceuticals Limited, OASIS Medical.

Latest Developments

• In May 2023, Bausch + Lomb acquired Blink Tears from Johnson & Johnson Vision. This acquisition strengthens Bausch + Lomb’s over-the-counter eye care product portfolio, expanding its market reach in the dry eye treatment space.
• In October 2022, Novartis received FDA approval for its Xiidra (lifitegrast ophthalmic solution) for the treatment of dry eye disease in patients 17 years and older. The approval enhances the company’s stronghold in the growing dry eye market by offering a proven therapeutic solution.

Report Scope

Dry Eye Syndrome Treatment Market, By Category

Product Type:

• Artificial Tears
• Anti-inflammatory Drugs
• Punctal Plugs
• Secretagogues
• Others

Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Region:

• North America
• Europe
• Asia-Pacific
• Rest of the World

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.